Response to: Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer’

被引：0

作者：

Vivian Y Shin

Ava Kwong

机构：

[1] The University of Hong Kong,Department of Surgery

[2] The Hong Kong Hereditary Breast Cancer Family Registry,Department of Surgery

[3] Hong Kong Sanatorium & Hospital,undefined

来源：

British Journal of Cancer | 2016年 / 114卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：e6 / e6

共 50 条

[41] Aggressive subgroups of metastatic triple-negative breast cancer: Inflammatory breast cancer and young patients in the Dana-Farber cell-free DNA cohort
Singh, J.
Asad, S.
Nock, W.
Zhang, Y.
Adams, E.
Damicis, A.
Parsons, H. A.
Adalsteinsson, V. A.
Winer, E. P.
Lin, N. U.
Partridge, A. H.
Overmoyer, B.
Stover, D. G.
CANCER RESEARCH, 2019, 79 (04)
[42] Triple-Negative Breast Cancer: Not Entirely Negative
Leone, Jose Pablo
Puhalla, Shannon
ONCOLOGY-NEW YORK, 2013, 27 (09): : 856 - +
[43] Circulating cell-free DNA: a potential biomarker in lung cancer
Taylor, Fiona
Teare, M. Dawn
Cox, Angela
Woll, Penella J.
LUNG CANCER MANAGEMENT, 2013, 2 (05) : 407 - 422
[44] Circulating cell-free DNA in serum as a biomarker of colorectal cancer
da Silva Filho, Benisio Ferreira
Almeida Diniz Gurgel, Ana Pavla
de Freitas Lins Neto, Manoel Alvaro
de Azevedo, Dalmo Almeida
de Freitas, Antonio Carlos
Silva Neto, Jacinto da Costa
Ferreira Silva, Luiz Antonio
JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (09) : 775 - 778
[45] TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis
Medford, Arielle J.
Oshry, Lauren
Boyraz, Baris
Kiedrowski, Lesli
Menshikova, Sofia
Butusova, Anna
Dai, Charles S.
Gogakos, Tasos
Keenan, Jennifer C.
Occhiogrosso, Rachel H.
Ryan, Phoebe
Lennerz, Jochen K.
Spring, Laura M.
Moy, Beverly
Ellisen, Leif W.
Bardia, Aditya
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
[46] Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction
Coleman, Michael F.
O'Flanagan, Ciara H.
Pfeil, Alexander J.
Chen, Xuewen
Pearce, Jane B.
Sumner, Susan
Krupenko, Sergey A.
Hursting, Stephen D.
NUTRIENTS, 2021, 13 (05)
[47] Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer
Llinas-Arias, Pere
Iniguez-Munoz, Sandra
McCann, Kelly
Voorwerk, Leonie
Orozco, Javier I. J.
Ensenyat-Mendez, Miquel
Sese, Borja
DiNome, Maggie L.
Marzese, Diego M.
CANCERS, 2021, 13 (16)
[48] Detection and quantification of triple-negative breast cancer (TNBC) across ethnicities through analysis of cell-free DNA (cfDNA) methylation
Cance, William
Liu, Edison
Antonio, Margaret
Shaver, Timothy
Shih, Stephannie
Chu, Bong Chul
Kurtzman, Kathryn
Newman, Lisa
CANCER RESEARCH, 2024, 84 (09)
[49] Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer
Stover, Daniel G.
Parsons, Heather A.
Ha, Gavin
Freeman, Samuel S.
Barry, William T.
Guo, Hao
Choudhury, Atish D.
Gydush, Gregory
Reed, Sarah C.
Rhoades, Justin
Rotem, Denisse
Hughes, Melissa E.
Dillon, Deborah A.
Partridge, Ann H.
Wagle, Nikhil
Krop, Ian E.
Getz, Gad
Golub, Todd R.
Love, J. Christopher
Winer, Eric P.
Tolaney, Sara M.
Lin, Nancy U.
Adalsteinsson, Viktor A.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06) : 543 - +
[50] Spatial predictors of immunotherapy response in triple-negative breast cancer
Xiao Qian Wang
Esther Danenberg
Chiun-Sheng Huang
Daniel Egle
Maurizio Callari
Begoña Bermejo
Matteo Dugo
Claudio Zamagni
Marc Thill
Anton Anton
Stefania Zambelli
Stefania Russo
Eva Maria Ciruelos
Richard Greil
Balázs Győrffy
Vladimir Semiglazov
Marco Colleoni
Catherine M. Kelly
Gabriella Mariani
Lucia Del Mastro
Olivia Biasi
Robert S. Seitz
Pinuccia Valagussa
Giuseppe Viale
Luca Gianni
Giampaolo Bianchini
H. Raza Ali
Nature, 2023, 621 : 868 - 876

← 1 2 3 4 5 →